Citalopram
- Level
- Commodity
- Parent
- 51292000
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51292004This classification denotes a selective serotonin reuptake inhibitor and antidepressant agent with the molecular formula C20H21FN2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0DHU5B8D6V, chemically known as 1,3-dihydro-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-5-isobenzofurancarbonitrile but generally known as citalopram, which bears US NIH Compound Identifier 2771. European Medicines Agency schedules Citalopram in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07485MIG. The term CITALOPRAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). World Health Organization schedules citalopram in its Anatomical Therapeutic Chemical (ATC) Classification. CITALOPRAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule citalopram under HS 29329985 and SITC 51569. As of Q4 2014, CITALOPRAM remains the US FDA Preferred Term for this commodity. Citalopram bears US NLM identifiers UMLS ID C0008845 and NCI Concept Code C61680. SMILES: Fc1ccc(C2(OCc3c2ccc(c3)C#N)CCCN(C)C)cc1.
Same parent
Under 51292000 · 29Activities that produce or sell this
KBLI · 8Inherited from family 51290000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.